2025
SJR Q1
JCR Q1 · 6,7
17 matched articles
SCIE
Journal detail
Chinese Journal of Cancer Research
- Publisher
- Chinese Journal of Cancer Research Co., Ltd. and Peking University Cancer Hospital and Institute
- Country
- Hong Kong · Asiatic Region
- Type
- journal
- ISSN
-
1000960419930631
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,406
- Quartile Q1
- H-Index 51
- Cites/doc 5,92
- Docs (3y) 169
- Cites (3y) 920
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,7
- 5Y JIF 6,2
- JCI 1,08
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Oncology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,406 | 6,7 | 6,2 | 1,08 | Q1 | 51 |
| 2024 | — | Q1 | — | 6,3 | 5,2 | 0,96 | Q2 | — |
| 2023 | — | Q1 | — | 7 | 5,6 | 0,84 | Q2 | — |
| 2022 | — | Q2 | — | 5,1 | 5 | 0,66 | Q3 | — |
| 2021 | — | Q3 | — | 4 | 4,5 | 0,83 | Q2 | — |
| 2020 | — | Q2 | — | 5,1 | 4,5 | 0,78 | Q2 | — |
| 2019 | Q2 | Q2 | 0,924 | 4,1 | 3,2 | 0,8 | Q2 | 44 |
| 2018 | — | Q3 | — | 2,5 | 2,6 | 0,74 | Q2 | — |
| 2017 | Q2 | Q2 | 1,061 | 3,7 | 2,5 | 0,69 | Q2 | 44 |
| 2016 | Q2 | Q2 | 0,939 | 3 | 2,3 | — | — | 44 |
| 2015 | Q2 | Q3 | 0,75 | 2,2 | 1,8 | — | — | 44 |
| 2014 | Q3 | Q3 | 0,587 | 1,9 | 1,3 | — | — | 44 |
| 2013 | Q3 | Q4 | 0,231 | 0,9 | 0,5 | — | — | 44 |
| 2012 | Q3 | Q4 | 0,206 | 0,4 | 0,3 | — | — | 44 |
| 2011 | Q4 | Q4 | 0,135 | 0,2 | — | — | — | 44 |
| 2010 | Q4 | Q4 | 0,119 | 0,3 | — | — | — | 44 |
| 2009 | — | Q4 | — | 0,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 58/333 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q2 | 51/328 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q2 | 41/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q3 | 76/241 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q2 | 135/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 89/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 83/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q2 | 148/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 86/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 108/217 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 143/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 156/211 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 189/203 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 191/197 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 188/196 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 174/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 161/166 |